Prenetics Global posts Q3 revenue surge but widens loss outlook

Prenetics Global reported third‑quarter 2026 revenue of $64.1 million, a year‑over‑year increase of over 170%. The quarter ended with a net loss of $25.4 million and the company expanded its second‑half adjusted EBITDA loss guidance to $30‑35 million. Management highlighted strong growth spending and a 64% gross margin, while investors pushed the share price down 37‑42.5% on the widened loss outlook.

The raised loss guidance triggered a sharp stock decline, reflecting investor concern over near‑term profitability. The updated outlook also signals higher cash burn before the company expects its growth investments to pay off.

  • YoY revenue growth reported as 228% versus 171.6%.
  • Second‑half adjusted EBITDA loss guidance given as $30‑35 million and $17‑22 million.

Sources